Secondary pooled analysis of two phase 3 RCTs (3136 participants) in uncomplicated UTI: gepotidacin and nitrofurantoin gave similar early symptom relief; 53.2% vs 53.6% with moderate-severe symptoms reported no impact on daily activities on therapy.
Secondary analysisn = 3,136
Sheets et al. Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies